A Vaccine Targeting Aged Cells Mitigates Metabolic Disorders in Obese Mice

Phoenix666 writes:

A vaccine targeting aged cells mitigates metabolic disorders in obese mice:

Aging is a multifaceted process that affects our bodies in many ways. In a new study, researchers from Osaka University developed a novel vaccine that removes aged immune cells and then demonstrated an improvement of diabetes-associated metabolic derangements by vaccinating obese mice.

Aged, or senescent, cells are known to harm their surrounding younger cells by creating an inflammatory environment. A specific type of immune cell, called T cell, can accumulate in fat tissues in obese individuals in senescence, causing chronic inflammation, metabolic disorders and heart disease. To reduce the negative effects of senescent cells on the body, senotherapy was developed to target and eliminate these rogue cells. However, as this approach does not discriminate between different types of senescent cells, it has remained unknown whether specific depletion of senescent T cells can improve their adverse effects on organ physiology.

[...] To achieve their goal, the researchers developed a novel vaccine targeting the surface protein CD153 that is present on senescent T cells populating fat tissues, thereby ensuring that normal T cells are not affected. To test the effects of their vaccine, the researchers fed mice with a high-fat diet to make them obese and ultimately to mimic the metabolic changes seen in diabetes. These include insulin resistance and an improperly functioning glucose metabolism, both of which can facilitate a deterioration of the eyes, kidneys, nerves and the heart. When they vaccinated these mice against CD153, the researchers observed a sharp decline of senescent T cells in the fat tissues of the mice, demonstrating the success of their approach.

Read more of this story at SoylentNews.